Back
Open Access

Introduction and a clinical case of a patient with HFrEF

Session: Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy
Topic: Chronic Heart Failure
Speaker: Doctor M. Kosiborod (Kansas City, US)
Sponsored by PACE-CME - Supported by an unrestricted educational grant from AstraZeneca
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
55 presentations
9 followers

4 more presentations in this session

The key role of RAASi-based therapy in symptomatic heart failure

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Access
Slides
Video
Thumbnail

Clinical choices in tackling the risk of hyperkalaemia

Speaker: Doctor M. Kosiborod (Kansas City, US) Doctor S. Zieroth (Winnipeg, CA) Doctor A. Wong (Bridgend, GB)

Access
Slides
Video
Thumbnail

A practical model for optimising RAASi-based therapy

Speaker: Doctor A. Wong (Bridgend, GB)

Access
Slides
Video
Thumbnail

Summary and conclusions

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access
Slides
Video
Thumbnail

Access the full session

Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy

Speakers: Doctor M. Kosiborod, Doctor S. Zieroth, Doctor M. Kosiborod, Doctor S. Zieroth, Doctor A. Wong...
Access
Video
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources